[{"NetIncomeLoss_1_Q2_USD":-41563000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":68395703.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":68332943.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":1000000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":34097000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":31064000.0,"RestrictedCashCurrent_0_Q2_USD":210000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":2216000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":97460000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":27000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":130827000.0,"Depreciation_2_Q2_USD":706000.0,"Depreciation_1_Q2_USD":416000.0,"DividendsCommonStockCash_2_Q2_USD":0.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1_Q2_USD":0.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_2_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":244810000.0,"CashCollateralForBorrowedSecurities_0_Q2_USD":210000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":42448000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":21848000.0,"ContractWithCustomerLiability_0_Q2_USD":0.0,"CostOfGoodsAndServicesSold_2_Q2_USD":2466000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":2466000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9944017.0,"IncomeTaxesPaidNet_2_Q2_USD":854000.0,"DepreciationAndAmortization_2_Q2_USD":1029000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":48000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":61000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":337000.0,"ShortTermInvestments_0_Q2_USD":57913000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":279000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":52628000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":23945000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":250000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":1000000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":2753000.0,"AccountsReceivableNetCurrent_0_Q2_USD":2551000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.7692,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.7599,"IncomeTaxExpenseBenefit_2_Q2_USD":1224000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1014000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":4165000.0,"ContractWithCustomerAssetNet_0_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":225866000.0,"IncreaseDecreaseInInventories_2_Q2_USD":6381000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-90986000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-41515000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":3654000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0101,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0107,"OtherAssetsNoncurrent_0_Q2_USD":5813000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":167953000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3500000.0,"Liabilities_0_Q2_USD":43423000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1993000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":2272000.0,"Assets_0_Q2_USD":279208000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":5386000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":1000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":1000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":5436000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":61000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":48000.0,"OperatingLossCarryforwards_0_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-89823000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-40549000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5717000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-78905000.0,"LiabilitiesCurrent_0_Q2_USD":38782000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":53915000.0,"AccountsPayableCurrent_0_Q2_USD":4156000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":168163000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":1993000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":9802000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":359000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q2_pure":0.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.0,"AdditionalPaidInCapital_0_Q2_USD":844260000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":20000000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":19750000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":14250000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3449000.0,"NetIncomeLoss_2_Q2_USD":-91047000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2551000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-608520000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_1_Q2_USD":887000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":248400000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":196000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":7704000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":7704000.0,"OperatingIncomeLoss_2_Q2_USD":-89838000.0,"OperatingIncomeLoss_1_Q2_USD":-40555000.0,"InventoryNet_0_Q2_USD":6381000.0,"InvestmentIncomeInterest_2_Q2_USD":15000.0,"InvestmentIncomeInterest_1_Q2_USD":6000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":20000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":279208000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":7892000.0,"ShareBasedCompensation_2_Q2_USD":12843000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":12843000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":8885000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2636000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":500000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.33,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.61,"ProfitLoss_2_Q2_USD":-91047000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1141000.0,"OtherLiabilitiesCurrent_0_Q2_USD":926000.0,"StockholdersEquity_0_Q2_USD":235785000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":113000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":1000000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-603000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5717000.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_Q2_USD":36551000.0,"Ticker":"KNSA","CIK":"1730430","name":"KINIKSA PHARMACEUTICALS, LTD.","OfficialName":"Kiniksa Pharmaceuticals Ltd. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"764985918.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]